Publication: Assessing the value of moderate‐to‐severe atopic dermatitis treatment using multi‐criteria decision analysis (MCDA)
dc.contributor.author | Pereyra-Rodriguez, Jose Juan | |
dc.contributor.author | Poveda, José Luis | |
dc.contributor.author | Rivero, Alvaro | |
dc.contributor.author | Serra-Baldrich, Esther | |
dc.contributor.author | Silvestre, Juan Francisco | |
dc.contributor.author | Armario-Hita, José Carlos | |
dc.contributor.author | Calleja, Miguel Angel | |
dc.contributor.author | Carrascosa, Jose Manuel | |
dc.contributor.author | Florez, Angeles | |
dc.contributor.author | Herranz, Pedro | |
dc.contributor.author | Comellas, Marta | |
dc.contributor.author | Ortiz de Frutos, Francisco Javier | |
dc.contributor.authoraffiliation | [Pereyra-Rodríguez,JJ] Dermatology Department, Hospital Universitario Virgen del Rocío, Sevilla, Spain. | |
dc.contributor.authoraffiliation | [Armario-Hita,JC] Dermatology Department, Hospital Universitario de Puerto Real, University of Cádiz, Cádiz, Spain. | |
dc.contributor.authoraffiliation | [Carrascosa,JM] Pharmacy Department, Hospital Universitario Virgen Macarena, Sevilla, Spain. | |
dc.date.accessioned | 2025-06-10T08:47:50Z | |
dc.date.available | 2025-06-10T08:47:50Z | |
dc.date.issued | 2024-01-01 | |
dc.description.abstract | The increased understanding of atopic dermatitis (AD) pathophysiology has shed light on the underlying immunologic mechanisms and spurred the development of novel, more precisely targeted therapies. As new agents become available, assessing their added value is advisable. Yet the value of novel health interventions sometimes remains largely unmeasured and inadequately understood. Value assessment is challenging since it involves assessing the extent to which it meets current unmet needs. Therefore, it is necessary to establish the most relevant health outcomes from different stakeholders' perspectives. | |
dc.description.version | Yes | |
dc.identifier.citation | Pereyra‐Rodríguez JJ, Poveda JL, Rivero A, Serra‐Baldrich E, Silvestre JF, Armario‐Hita JC et al. Assessing the value of moderate‐to‐severe atopic dermatitis treatment using multi‐criteria decision analysis (MCDA). JEADV 2024;38:e59‐e62 | |
dc.identifier.doi | 10.1111/jdv.19432 | |
dc.identifier.issn | 0926-9959 | |
dc.identifier.pmid | 37594914 | |
dc.identifier.uri | https://hdl.handle.net/10668/28520 | |
dc.issue.number | 1 | |
dc.journal.title | Journal of the European Academy of Dermatology and Venereology | |
dc.language.iso | en | |
dc.page.number | e59-e62 | |
dc.publisher | Wiley | |
dc.relation.publisherversion | https://onlinelibrary.wiley.com/doi/10.1111/jdv.19432 | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International | en |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Atopic dermatitis | |
dc.subject | Multi‑criteria decision analysis (MCDA) | |
dc.subject | Health-related quality of life (HRQoL) | |
dc.subject | Pruritus reduction | |
dc.subject | Disease activity control | |
dc.subject.decs | Dermatitis atópica | |
dc.subject.decs | Análisis de decisión multicriterio | |
dc.subject.decs | Calidad de vida relacionada con la salud | |
dc.subject.decs | Reducción del prurito | |
dc.subject.decs | Control de la actividad de la enfermedad | |
dc.subject.mesh | Decision Making | |
dc.subject.mesh | Decision Support Techniques | |
dc.subject.mesh | Dermatitis, Atopic | |
dc.title | Assessing the value of moderate‐to‐severe atopic dermatitis treatment using multi‐criteria decision analysis (MCDA) | |
dc.type | letter | |
dc.type.hasVersion | AM | |
dc.volume.number | 38 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- MCDA_JEADV.pdf
- Size:
- 342.87 KB
- Format:
- Adobe Portable Document Format